Committee Recommends FDA Approval of Antibiotic to Treat Intra-Abdominal Infections, UTIs

December 8, 2014 3:03 PM

2 0

The Anti-Infective Drugs Advisory Committee is recommending that the FDA approve of Actavis’s new drug application for ceftazidime-avibactam, an investigational antibiotic.

The antibiotic is being created to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI), in combination with metronidazole, as well as complicated urinary tract infections (cUTI) caused by gram-negative pathogens, according ...

Read more

To category page

Loading...